SCHEMBL20866660

SCHEMBL20866660

N=C(NC1N=C(c2ccccc2)c2ccccc2NC1=O)OC(=N)c1ccc(F)nc1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 17/20 0.59
▸ CCKAR P32238 11/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866970 0.89 CCKBR (0.71) CCKBRCCKAR
SCHEMBL24612046 0.88 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20866819 0.88 CCKBR (0.63) CCKBRCCKAR
SCHEMBL20866996 0.86 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20867275 0.86 CCKBR (0.67) CCKBRCCKAR
SCHEMBL20866706 0.85 CCKBR (0.56) CCKBRCCKAR
SCHEMBL20866579 0.85 CCKBR (0.71) CCKBRCCKAR
SCHEMBL20866662 0.85 CCKBR (0.58) CCKBRCCKAR
SCHEMBL24612045 0.84 CCKBR (0.74) CCKBRCCKAR
SCHEMBL20866563 0.84 CCKBR (0.60) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback